About Surgical Site Infections
Preventing and Treating Surgical Site Infections
About Collatamp G
Preventing and Treating Surgical Site Infections with Collatamp G
Request Study Reprints or Sample for Product Evaluation
Improve Patient Safety, Surgical Outcomes and Wait Times
If you're a surgeon, you're likely aware of some sobering statistics surrounding surgical site infections.
Patients with a surgical site infection:
- Are twice as likely to die as patients with no infection
- Are five times more likely to be readmitted to hospital
- Are 60% more likely to require time in the ICU
- Spend an average of eight additional days in the hospital at a cost of $4,000
- Are at increased risk of repeat surgery, or surgical revision.
Despite best practices implementation, including Safer Healthcare Now guidelines, an estimated 50,000 Canadians a year suffer a surgical site infection, costing the Canadian healthcare system over $200 million annually.
These infections are responsible for consuming more than 400,000 additional hospital days annually, resulting in surgery postponements, hampered OR throughput and increased surgical wait-times.
Now Available in Canada, Collatamp G Is a Clinically Proven Anti-Infective Surgical Implant for the Treatment of Local Infections and Prevention of Surgical Site Infection
Collatamp G is a fully resorbable collagen "sponge" impregnated with high doses of fast-release gentamicin for local delivery of broad spectrum antibiotic where it's needed, when it's needed.
Collatamp G has demonstrated a 50-85% reduction in surgical site infections across 42 clinical studies involving more than 4,700 patients.
This breakthrough medical device is approved in 50 countries, and has been used for over 20 years in two million patients worldwide with no reported adverse events.
When used in high-risk patients, Collatamp G demonstrates hospital cost savings from reduced length-of-stay, reduced revision procedures and repeat surgeries, even at surgical site infection rates as low as:
- Cardiac: 1.7%
- Hip replacement: 2.1%
- Colorectal surgery: 5.6%
Watch this video for an overview, then follow the links to learn more:
Get the Flash Player to see this player.
Learn more about the impact of surgical site infections and new developments in preventing them:
